Dennis F Moore

Dennis F Moore

UNVERIFIED PROFILE

Are you Dennis F Moore?   Register this Author

Register author
Dennis F Moore

Dennis F Moore

Publications by authors named "Dennis F Moore"

Are you Dennis F Moore?   Register this Author

41Publications

1077Reads

7Profile Views

Glioblastoma and Increased Survival with Longer Chemotherapy Duration.

Kans J Med 2019 Aug 21;12(3):65-69. Epub 2019 Aug 21.

University of Kansas School of Medicine-Wichita.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710024PMC
August 2019

Small Lymphocytic Lymphoma Presenting with Hypopituitarism.

Am J Med 2016 Jan 5;129(1):e9-e10. Epub 2015 Sep 5.

Cancer Center of Kansas, Wichita.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2015.08.016DOI Listing
January 2016

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant.

Case Rep Transplant 2015 25;2015:801082. Epub 2015 Nov 25.

Department of Internal Medicine, University of Kansas School of Medicine-Wichita, 1010 N. Kansas Street, Wichita, KS 67214, USA.

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/crit/2015/801082.pdf
Web Search
http://www.hindawi.com/journals/crit/2015/801082/
Publisher Site
http://dx.doi.org/10.1155/2015/801082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673324PMC
December 2015

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.

J Natl Cancer Inst 2015 Nov 14;107(11). Epub 2015 Sep 14.

NRG Oncology/National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA (CJA, GY, MJO, RWB, TFW, HCP, AFS, JCL, DPR, AA, LSE, NB, GS, JFE, JMR, DFMJr, MRM, BTM, PJW, SS, MSR, NW); Department of Medicine, University of Florida Health, Gainesville, FL (CJA); NRG Oncology and the University of Pittsburgh Graduate School of Public Health, Department of Biostatistics, Pittsburgh, PA (GY); Glendale Memorial Hospital, Glendale, CA (RWB); CCOP Christiana Care Health Systems, Newark, DE (TFW); Mayo Clinic, Rochester, MN and the ALLIANCE, Boston, MA (HCP); Wayne State University, Karmanos Cancer Institute, Detroit, MI and SWOG, San Antonio, TX (AFS); Emory University, Department of Radiation Oncology, Atlanta, GA and ECOG/ACRIN, Rochester, MN (JCL); Massachusetts General Hospital Cancer Center and the ALLIANCE, Boston, MA (DPR); Kaiser Permanente, Fremont, CA (AA); Novant Health Forsyth Medical Center, Winston-Salem, NC (LSE); University of Pittsburgh, Pittsburgh, PA (NB); Missouri Valley Cancer Consortium CCOP, Omaha, NE (GS); Florida Cancer Specialists, Fort Myers, FL (JFE); Beaumont Hospital System, Royal Oak, MI (JMR); Cancer Center of Kansas, Wichita, KS (DFMJr); Stroger Hospital Chicago MU-NCORP, Chicago, IL (MRM); Montana Cancer Consortium, Billings, MT (BTM); Oncology and Hematology Care, Cincinnati, OH (PJW); UF Health Cancer Center, Orlando FL (MSR); Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA (NW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849360PMC
November 2015

Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial.

J Clin Oncol 2015 May 20;33(15):1653-9. Epub 2015 Apr 20.

Stephen R. Rapp, L. Doug Case, Ann Peiffer, Michelle M. Naughton, Michael D. Chan, and Edward G. Shaw, Wake Forest School of Medicine and Wake Forest Community Clinical Oncology Program Research Base; Volker W. Stieber, Novant Health System, Winston-Salem, NC; Dennis F. Moore Jr, Wichita Community Clinical Oncology Program, Wichita, KS; Steven C. Falchuk, Christiana Care Health Services, Newark, DE; James V. Piephoff, Mercy Hospital, St Louis, MO; William J. Edenfield and Jeffrey K. Giguere, Cancer Center of Carolinas, Greenville, SC; and Monica E. Loghin, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.4508DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429174PMC
May 2015

Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.

J Clin Oncol 2014 Jun 5;32(18):1927-34. Epub 2014 May 5.

Michael J. O'Connell, Linda H. Colangelo, Robert W. Beart, Nicholas J. Petrelli, Carmen J. Allegra, Saima Sharif, Henry C. Pitot, Anthony F. Shields, David S. Parda, Mohammed Mohiuddin, Amit Arora, Lisa S. Evans, Nathan Bahary, Gamini S. Soori, Janice Eakle, John M. Robertson, Dennis F. Moore Jr, Michael R. Mullane, Benjamin T. Marchello, Patrick J. Ward, Timothy F. Wozniak, Mark S. Roh, Greg Yothers, Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers; David S. Parda, Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital; Nathan Bahary, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robert W. Beart, Colorectal Surgery Institute, Glendale Memorial Hospital, Glendale; Amit Arora, Kaiser Permanente Hayward, Hayward, CA; Nicholas J. Petrelli, Timothy F. Wozniak, Helen F. Graham Cancer Center at Christiana Care Health Service, Newark, DE; Carmen J. Allegra, University of Florida, Gainesville; Janice Eakle, Florida Cancer Specialists, Sarasota; Mark S. Roh, MD Anderson Cancer Center Orlando Health, Orlando, FL; Henry C. Pitot, Mayo Clinic, Rochester, MN; Anthony F. Shields, Karmanos Cancer Institute/Southwest Oncology Group, Detroit; John M. Robertson, Beaumont Hospital System, Royal Oak, MI; Jerome C. Landry, Eastern Cooperative Oncology Group/Emory University, Winship Cancer Institute, Atlanta, GA; David P. Ryan, Massachusetts General Hospital Cancer Center, Boston, MA; Lisa S. Evans, Community Clinical Oncology Program, Southeast CCC Novant Health Derrick L. Davis Forsyth Medical Center, Winston-Salem, NC; Gamini S. Soori, Missouri Valley Cancer Consortium Community Clinical Oncology Program, Omaha, NE; Dennis Moore Jr, Community Clinical Oncology Program, Wichita/St Francis Regional Medical Center/Via Christi Regional Medical Center, Wichita, KS; Michael R. Mullane, Minority-Based Community Clinical Oncology Program John H. Stroger Jr Hospital

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.53.7753
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.53.7753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050205PMC
June 2014

Benign metastasizing leiomyomatosis: case report and review.

Am J Clin Oncol 2003 Oct;26(5):473-6

University of Kansas School of Medicine-Wichita, Wichita, Kansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000037737.78080.E3DOI Listing
October 2003

Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer.

Am J Clin Oncol 2002 Oct;25(5):451-3

Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000421-200210000-00005DOI Listing
October 2002

The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study.

Invest New Drugs 2002 Feb;20(1):117-21

Hematology Oncology Associates, Lake Worth, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1014493007347DOI Listing
February 2002